Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7340991 | 1.00 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL2094911 | 1.00 | — | — | |
| SCHEMBL9479478 | 1.00 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL2091621 | 0.97 | — | — | |
| SCHEMBL1446393 | 0.89 | — | — | |
| SCHEMBL1714641 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHR | |
| SCHEMBL8812303 | 0.83 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8810614 | 0.83 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8810576 | 0.83 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1714843 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402358-A2 | 2',3'-Didehydro-3'-deoxy-4'-ethynylothymidine derivatives for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and pharmaceutically acceptable forms of drugs | Instytut Biochemii I Biofizyki Pan (PL) | 2012-01-04 | — | — | EP | claimed |
| US-6602861-B1 | Acylated phospholipid drugs | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2003-08-05 | — | — | US | claimed |
| EP-0636134-B1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RES CORP TECHNOLOGIES INC (US) | 1997-12-17 | — | — | EP | claimed |
| EP-0636134-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-02-01 | — | — | EP | claimed |
| WO-1993021191-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-28 | — | — | WO | claimed |
| EP-2402358-A3 | 2',3'-Didehydro-3'-deoxy-4'-ethynylothymidine derivatives for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and pharmaceutically acceptable forms of drugs | Instytut Biochemii I Biofizyki Pan (PL) | 2012-07-18 | — | — | EP | disclosed |
| EP-2402358-A2 | 2',3'-Didehydro-3'-deoxy-4'-ethynylothymidine derivatives for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and pharmaceutically acceptable forms of drugs | Instytut Biochemii I Biofizyki Pan (PL) | 2012-01-04 | — | — | EP | disclosed |
| EP-2402358-A2 | 2',3'-Didehydro-3'-deoxy-4'-ethynylothymidine derivatives for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and pharmaceutically acceptable forms of drugs | Instytut Biochemii I Biofizyki Pan (PL) | 2012-01-04 | — | — | EP | disclosed |
| EP-2402356-A2 | Modified 2',3'-dideoxynucleosides for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and the pharmaceutical agent containing these nucleosides | Instytut Biochemii I Biofizyki Pan (PL) | 2012-01-04 | — | — | EP | disclosed |
| US-20110027911-A1 | SOLUBILIZATION AND STUDY OF MEMBRANE PROTEINS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2011-02-03 | — | — | US | disclosed |
| WO-2009089430-A1 | SOLUBILIZATION AND STUDY OF MEMBRANE PROTEINS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-07-16 | — | — | WO | disclosed |
| US-6602861-B1 | Acylated phospholipid drugs | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2003-08-05 | — | — | US | disclosed |
| US-5846955-A | Acylated phospholipid drugs | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0636134-B1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RES CORP TECHNOLOGIES INC (US) | 1997-12-17 | — | — | EP | disclosed |
| EP-0636134-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-02-01 | — | — | EP | disclosed |
| WO-1993021191-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-28 | — | — | WO | disclosed |